These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 20048432)

  • 1. [Calcium antagonists: current and future applications based on new evidence. Effects of calcium channel blockers on oxidative stress].
    Nishiyama A; Nakano D; Hitomi H
    Clin Calcium; 2010 Jan; 20(1):38-44. PubMed ID: 20048432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Calcium antagonists: current and future applications based on new evidence. Pleiotropic effects of calcium channel blockers on vascular endothelial function].
    Morimoto Y; Kureishi-Bando Y; Murohara T
    Clin Calcium; 2010 Jan; 20(1):69-75. PubMed ID: 20048436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Calcium antagonists: current and future applications based on new evidence. Classification of calcium channel blockers].
    Takahara A
    Clin Calcium; 2010 Jan; 20(1):24-30. PubMed ID: 20048430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of neuronal damage by calcium channel blockers with antioxidative effects after transient focal ischemia in rats.
    Lukic-Panin V; Kamiya T; Zhang H; Hayashi T; Tsuchiya A; Sehara Y; Deguchi K; Yamashita T; Abe K
    Brain Res; 2007 Oct; 1176():143-50. PubMed ID: 17904110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of calcium channel blockers for glaucoma.
    Araie M; Mayama C
    Prog Retin Eye Res; 2011 Jan; 30(1):54-71. PubMed ID: 20933604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current status of safety and efficacy of calcium channel blockers in cardiovascular diseases: a critical analysis based on 100 studies.
    Opie LH; Yusuf S; Kübler W
    Prog Cardiovasc Dis; 2000; 43(2):171-96. PubMed ID: 11014332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effects of calcium channel blockers in atherosclerosis and cardiovascular event and oxidative vascular damage].
    Fujino T; Sumitomo K; Hasebe N; Kikuchi K
    Clin Calcium; 2004 Jan; 14(1):119-27. PubMed ID: 15576967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Calcium antagonists: current and future applications based on new evidence. Calcium channel blockers in the elderly with hypertension].
    Ohishi M; Rakugi H
    Clin Calcium; 2010 Jan; 20(1):100-6. PubMed ID: 20048441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calcium channel blockers and coronary heart disease.
    Inzitari M; Di Bari M; Marchionni N
    Aging Clin Exp Res; 2005 Aug; 17(4 Suppl):6-15. PubMed ID: 16640169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Benidipine, an anti-hypertensive drug, inhibits reactive oxygen species production in polymorphonuclear leukocytes and oxidative stress in salt-loaded stroke-prone spontaneously hypertensive rats.
    Matsubara M; Akizuki O; Ikeda J; Saeki K; Yao K; Sasaki K
    Eur J Pharmacol; 2008 Feb; 580(1-2):201-13. PubMed ID: 18048030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Calcium antagonists: current and future applications based on new evidence. The mechanisms on lowering serum uric acid level by calcium channel blockers].
    Mizuta E; Hamada T; Igawa O; Shigemasa C; Hisatome I
    Clin Calcium; 2010 Jan; 20(1):45-50. PubMed ID: 20048433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Calcium antagonists: current and future applications based on new evidence. Calcium channel blockers and JSH2009].
    Ebina T; Kimura K; Umemura S
    Clin Calcium; 2010 Jan; 20(1):16-22. PubMed ID: 20048429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of calcium channel and renin-angiotensin system blockade on intravascular and neurohormonal mechanisms of hypertensive vascular disease.
    Mizuno Y; Jacob RF; Mason RP
    Am J Hypertens; 2008 Oct; 21(10):1076-85. PubMed ID: 18756260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Calcium antagonists: current and future applications based on new evidence. Combination antihypertensive therapy with calcium channel blockers].
    Ishimitsu T
    Clin Calcium; 2010 Jan; 20(1):52-60. PubMed ID: 20048434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endothelium, atherosclerosis and calcium channel blockers.
    Biswas TK
    J Indian Med Assoc; 2003 Jul; 101(7):428-31. PubMed ID: 14748381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Calcium antagonists in cardiovascular disease. Clinical evidence from morbidity and mortality trials].
    Oparil S; Bakir SE
    Drugs; 2000; 59 Spec No 2():25-37. PubMed ID: 11002856
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The combined effect of calcium channel blocker Lercanidipine and antioxidants on low-grade systemic inflammation parameters in essential hypertension patients.
    Farah R; Shurtz-Swirski R
    Minerva Cardioangiol; 2008 Oct; 56(5):467-76. PubMed ID: 18813182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Calcium channel blockers and atherosclerosis].
    Hirata K; Yokoyama M
    Clin Calcium; 2004 Jan; 14(1):128-32. PubMed ID: 15576968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of essential hypertension with calcium channel blockers: what is the place of lercanidipine?
    Burnier M; Pruijm M; Wuerzner G
    Expert Opin Drug Metab Toxicol; 2009 Aug; 5(8):981-7. PubMed ID: 19619074
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Ca channel blocker and heart failure].
    Kinugawa S; Tsutsui H
    Clin Calcium; 2005 Oct; 15(10):1615-22. PubMed ID: 16199906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.